Literature DB >> 19565482

Association of adrenergic receptor gene polymorphisms with different fibromyalgia syndrome domains.

Gilberto Vargas-Alarcón1, José-Manuel Fragoso, David Cruz-Robles, Angélica Vargas, Aline Martinez, José-Ignacio Lao-Villadóniga, Ferrán García-Fructuoso, Maite Vallejo, Manuel Martínez-Lavín.   

Abstract

OBJECTIVE: Fibromyalgia (FM) patients have signs of relentless sympathetic hyperactivity associated with hyporeactivity to stress. Adrenergic receptors (ARs) are parts of the sympathetic nervous system that are fundamental for maintenance of homeostasis. We undertook this study to correlate alpha-AR and beta-AR gene polymorphisms with the presence of FM and with different domains of the FM syndrome as measured by the Fibromyalgia Impact Questionnaire (FIQ).
METHODS: We studied 78 Mexican FM patients and 48 age-matched controls as well as 78 Spanish FM patients and 71 controls. All subjects studied were women. Single-nucleotide polymorphisms (SNPs) of alpha(1A)-AR (rs574584, rs1383914, rs1048101, and rs573542), beta(2)-AR (rs1042713 and rs1042714), and beta(3)-AR (rs4994) were analyzed by 5' exonuclease TaqMan polymerase chain reaction. Polymorphic haplotypes were constructed after linkage disequilibrium analysis.
RESULTS: The beta(2)-AR AC haplotype was a risk factor for the presence of FM. This haplotype had an increased frequency in Mexican patients compared with Mexican controls (42.1% versus 30.5%; P = 0.04). Similarly, 50.4% of Spanish patients had this haplotype compared with 40.0% of Spanish controls (P = 0.05). In Spanish patients, the alpha(1A)-AR SNP rs1383914 was associated with the presence of FM (P = 0.01), and the alpha(1A)-AR SNP rs1048101 was linked with FIQ disability (P = 0.02). Mexican patients with the rs574584 GG genotype presented the highest FIQ score compared with Mexican patients with other genotypes (P = 0.01), and in Mexicans SNP rs574584 was associated with FIQ morning stiffness (P = 0.04) and with FIQ tiredness upon awakening (P = 0.02).
CONCLUSION: AR gene polymorphisms are related to the risk of developing FM and are also linked to different domains of the FM syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565482     DOI: 10.1002/art.24655

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  34 in total

1.  Exercise for fibromyalgia: evidence for an integrated modulation of autonomic and nociception neural regulation.

Authors:  Juvenia Bezerra Fontenele; Francisco Helder Cavalcante Felix
Journal:  Rheumatol Int       Date:  2011-11-09       Impact factor: 2.631

2.  A SCN9A gene-encoded dorsal root ganglia sodium channel polymorphism associated with severe fibromyalgia.

Authors:  Gilberto Vargas-Alarcon; Edith Alvarez-Leon; Jose-Manuel Fragoso; Angelica Vargas; Aline Martinez; Maite Vallejo; Manuel Martinez-Lavin
Journal:  BMC Musculoskelet Disord       Date:  2012-02-20       Impact factor: 2.362

Review 3.  Recent advances in the understanding of genetic susceptibility to chronic pain and somatic symptoms.

Authors:  Kate L Holliday; John McBeth
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

Review 4.  Fibromyalgia Pathogenesis and Treatment Options Update.

Authors:  Steven Chinn; William Caldwell; Karina Gritsenko
Journal:  Curr Pain Headache Rep       Date:  2016-04

Review 5.  Candidate gene studies of fibromyalgia: a systematic review and meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 6.  Fibromyalgia: from pathophysiology to therapy.

Authors:  Tobias Schmidt-Wilcke; Daniel J Clauw
Journal:  Nat Rev Rheumatol       Date:  2011-07-19       Impact factor: 20.543

Review 7.  Psychiatric aspects of chronic fatigue syndrome and fibromyalgia.

Authors:  Boudewijn Van Houdenhove; Stefan Kempke; Patrick Luyten
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 8.  The phenotypic and genetic signatures of common musculoskeletal pain conditions.

Authors:  Luda Diatchenko; Roger B Fillingim; Shad B Smith; William Maixner
Journal:  Nat Rev Rheumatol       Date:  2013-04-02       Impact factor: 20.543

9.  Results of a pilot multicenter genotype-based randomized placebo-controlled trial of propranolol to reduce pain after major thermal burn injury.

Authors:  Danielle C Orrey; Omar I Halawa; Andrey V Bortsov; Jeffrey W Shupp; Samuel W Jones; Linwood R Haith; Janelle M Hoskins; Marion H Jordan; Shrikant I Bangdiwala; Brandon R Roane; Timothy F Platts-Mills; James H Holmes; James Hwang; Bruce A Cairns; Samuel A McLean
Journal:  Clin J Pain       Date:  2015-01       Impact factor: 3.442

Review 10.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.